PureHealth Completes €800M Acquisition of Hellenic Healthcare Group
ABU DHABI, UAE, Oct. 7, 2025 — PureHealth Holding PJSC announced the completion of its €800 million acquisition of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ABU DHABI, UAE, Oct. 7, 2025 — PureHealth Holding PJSC announced the completion of its €800 million acquisition of...
BASEL, Switzerland, Oct. 6, 2025 — Roche announced that it has received CE-mark approval for the AI-based Kidney Klinrisk...
PARIS, Sept. 24, 2025 — Sanofi announced a $625 million capital expansion for its corporate venture fund, Sanofi Ventures,...
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
August 21, 2025: The U.S. Food and Drug Administration (FDA) has issued a public health advisory cautioning against consumption,...
ANKARA, Türkiye, August 18, 2025 — SmartAlpha’s AI-powered software, Nerveblox, designed to assist clinicians performing ultrasound-guided regional anesthesia (“nerve...
